Skip to content
GenoLensGenoLens

PRICKLE1

Chr 12q12

prickle planar cell polarity protein 1

Aliases:
FLJ31937, EPM1B, RILP
MANE:
ENST00000345127.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Early onset or syndromic epilepsy

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Adult onset neurodegenerative disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Ataxia and cerebellar anomalies - narrow panel

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia

    BIALLELIC, autosomal or pseudoautosomal
  • Hereditary ataxia with onset in adulthood

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Unverricht-Lundborg disease

    0.70
  • Abnormality of the skeletal system

    0.46
  • self-limited epilepsy with centrotemporal spikes

    0.45
  • Rolandic epilepsy

    0.45
  • obesity disorder

    0.41
  • Unverricht-Lundborg syndrome

    0.38
  • alcohol drinking

    0.37
  • colorectal cancer

    0.36
  • type 2 diabetes mellitus

    0.34
  • gout

    0.31

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Prickle-like protein 1

Involved in the planar cell polarity pathway that controls convergent extension during gastrulation and neural tube closure. Convergent extension is a complex morphogenetic process during which cells elongate, move mediolaterally, and intercalate between neighboring cells, leading to convergence toward the mediolateral axis and extension along the anteroposterior axis. Necessary for nuclear localization of REST. May serve as nuclear receptor

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.